Literature DB >> 28992974

Diazepam treatment reduces inflammatory cells and mediators in the central nervous system of rats with experimental autoimmune encephalomyelitis.

Nicolás Fernández Hurst1, Samanta R Zanetti2, Natalia S Báez3, Mario J Bibolini1, Cecilia Bouzat2, German A Roth4.   

Abstract

Benzodiazepines are psychoactive drugs and some of them also affect immune cells. We here characterized the inflammatory and infiltrating immune cells in the central nervous system (CNS) during the acute phase of experimental autoimmune encephalomyelitis (EAE) in animals treated with Diazepam. Also, we evaluated the expression of Translocator Protein (18kDa) (TSPO), which is a biomarker of neuroinflammatory diseases. The results indicate that Diazepam exerts protective effects on EAE development, decreasing the incidence of the disease and reducing the number of inflammatory cells in CNS, with a concomitant decrease of TSPO levels in brain tissue and CNS inflammatory CD11b+ cells.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autoimmunity; Diazepam; Inflammatory T cells; TSPO

Mesh:

Substances:

Year:  2017        PMID: 28992974     DOI: 10.1016/j.jneuroim.2017.09.012

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  4 in total

Review 1.  Opportunities for Molecular Imaging in Multiple Sclerosis Management: Linking Probe to Treatment.

Authors:  Aline M Thomas; Frederik Barkhof; Jeff W M Bulte
Journal:  Radiology       Date:  2022-04-26       Impact factor: 29.146

2.  Expression of Translocator Protein and [18F]-GE180 Ligand Uptake in Multiple Sclerosis Animal Models.

Authors:  Anne Nack; Matthias Brendel; Julia Nedelcu; Markus Daerr; Stella Nyamoya; Cordian Beyer; Carola Focke; Maximilian Deussing; Chloé Hoornaert; Peter Ponsaerts; Christoph Schmitz; Peter Bartenstein; Axel Rominger; Markus Kipp
Journal:  Cells       Date:  2019-01-28       Impact factor: 6.600

Review 3.  Catatonia and the immune system: a review.

Authors:  Jonathan P Rogers; Thomas A Pollak; Graham Blackman; Anthony S David
Journal:  Lancet Psychiatry       Date:  2019-06-10       Impact factor: 77.056

4.  Active Anti-Inflammatory and Hypolipidemic Derivatives of Lorazepam.

Authors:  Panagiotis Theodosis-Nobelos; Georgios Papagiouvannis; Panos N Kourounakis; Eleni A Rekka
Journal:  Molecules       Date:  2019-09-09       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.